Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Russell

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Antimicrobial Agents and Chemotherapy|April 1, 1997
Highly potent oxathiin carboxanilide derivatives with efficacy against nonnucleoside reverse transcriptase inhibitor-resistant human immunodeficiency virus isolatesR W Buckheit, M J Snow, V Fliakas-Boltz, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1995
Structure-activity and cross-resistance evaluations of a series of human immunodeficiency virus type-1-specific compounds related to oxathiin carboxanilideR W Buckheit, T L Kinjerski, V Fliakas-Boltz, et al.
Antiviral Research|March 12, 2010
In vitro resistance development for RO-0335, a novel diphenylether nonnucleoside reverse transcriptase inhibitorH Javanbakht, R G Ptak, E Chow, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1996
Biological and biochemical anti-human immunodeficiency virus activity of UC 38, a new non-nucleoside reverse transcriptase inhibitorJ B McMahon, R W Buckheit, R J Gulakowski, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Antimicrobial Agents and Chemotherapy|April 1, 1997
Highly potent oxathiin carboxanilide derivatives with efficacy against nonnucleoside reverse transcriptase inhibitor-resistant human immunodeficiency virus isolatesR W Buckheit, M J Snow, V Fliakas-Boltz, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1995
Structure-activity and cross-resistance evaluations of a series of human immunodeficiency virus type-1-specific compounds related to oxathiin carboxanilideR W Buckheit, T L Kinjerski, V Fliakas-Boltz, et al.
Antiviral Research|March 12, 2010
In vitro resistance development for RO-0335, a novel diphenylether nonnucleoside reverse transcriptase inhibitorH Javanbakht, R G Ptak, E Chow, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1996
Biological and biochemical anti-human immunodeficiency virus activity of UC 38, a new non-nucleoside reverse transcriptase inhibitorJ B McMahon, R W Buckheit, R J Gulakowski, et al.
Pageof 8